Placenta Previa Clinical Trials

Find Placenta Previa Clinical Trials Near You

Diagnostic Accuracy and Implementation Feasibility of AI-Assisted Blind Ultrasound Sweep (SPAQ E-con AI) for Antenatal Screening by Non-Specialist Health Workers in Rural Democratic Republic of the Congo

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

FS2 evaluates the diagnostic accuracy and implementation feasibility of an AI-assisted blind-sweep obstetric ultrasound (SPAQ E-con AI), operated by trained non-specialist health workers, for antenatal screening in rural Democratic Republic of the Congo. Primary outcomes are gestational age mean absolute error (Trimester 2 and Trimester 3) with 95% confidence intervals and AI confidence calibration. The reference standard is manual measurement by a reference reader (early ultrasound first; manual BPD if unavailable; last menstrual period is not used). Target enrollment is approximately 1,430 (IRB-approved ceiling 3,000), with early termination permitted upon achievement of pre-specified analysis-plan thresholds. The study is a multi-center prospective Hybrid Type 1 Effectiveness-Implementation design and includes a pre-specified adaptive model-update (Batch 2 cut) plan following FDA PCCP and STARD-AI guidance.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 16
Healthy Volunteers: t
View:

• Pregnant women

• Identified at a participating facility routine ANC visit or RECO village outreach within the Kenge health zone catchment

• Informed consent obtained (16-17 years with parent/guardian consent)

Locations
Other Locations
Democratic Republic of the Congo
DPS Kwango
RECRUITING
Kenge
Contact Information
Primary
Kuniyuki Furuta
furuta@soik.co.jp
+818099740409
Time Frame
Start Date: 2026-06-19
Estimated Completion Date: 2027-06-13
Participants
Target number of participants: 3000
Treatments
Cohort A
Natural enrollment / Description: Consecutive ANC attendees (natural prevalence)
Cohort B-1 Placenta/malpresentation enriched
Enriched validation subset for placenta praevia and fetal malpresentation
Cohort B-2 - Trimester 1 (CRL/GS) enriched
Enriched trimester 1 cases for CRL/GS gestational age models
Related Therapeutic Areas
Sponsors
Leads: SOIK Corporation Sarl

This content was sourced from clinicaltrials.gov